These results suggested that the probiotic powder inhibited CD4+ Foxp3+ Treg cells, increased the number of IFN-γ+ CD8+ T cells, CD4+ IL-4+ Th2 cells and CD19+ GL-7+ B cells in the immune microenvironment of CRC. The gene discussed is CD19; the disease is colorectal carcinoma.